Literature DB >> 8609243

Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells.

H Lerat1, F Berby, M A Trabaud, O Vidalin, M Major, C Trépo, G Inchauspé.   

Abstract

The presence of hepatitis C virus (HCV) negative strand RNA in extrahepatic compartments based on PCR detection assays has been suggested in many reports with a very heterologous detection rate (from 0 to 100%). In this study, we have analyzed the presence of HCV negative strand in hepatic (liver biopsies, n = 20) and extrahepatic (sera, n = 32; PBMC, n = 26 and fresh bone marrow cells, n = 8) compartments from infected patients with three different reverse transcriptase (RT)-PCR-based assays using primers located in the 5' noncoding region, with or without a tag selected to display different viral loads (10(5)-3 x 10(7) genomic equivalent/ml or gram) and viral genotypes (n = 5). Using synthetic as well as biological templates, we could document extensive artifactual detection of negative strand RNA, due to self priming and mispriming events, even either 5' noncoding region primer pair was used, whereas both artifacts were dramatically reduced (mispriming) or eliminated (selfpriming) using CAP-based RT-PCR assay. Mispriming artifacts were directly correlated to the titer of positive strand RNA present in the sample. Using the CAP-PCR assay, the presence of HCV negative strand RNA was found in 75% of livers (16:20) and only 8% of PBMC, independent of the genotype involved, but could not be documented in sera (0:32) and fresh bone marrow cells (0:6). These findings suggest that caution regarding the type of RT-PCR assay used and the level of HCV positive strand RNA present in the biological sample analyzed has to be taken to avoid false identification of viral reservoirs. The findings suggest that hematopoietic peripheral cells can support HCV replication, although in a very limited number of carriers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609243      PMCID: PMC507124          DOI: 10.1172/JCI118485

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Specific detection of minus strand hepatitis A virus RNA by Tail-PCR following reverse transcription.

Authors:  R L Chaves; J Graff; A Normann; B Flehmig
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

2.  A novel transcription property of SP6 and T7 RNA polymerases: dependence on template structure.

Authors:  E T Schenborn; R C Mierendorf
Journal:  Nucleic Acids Res       Date:  1985-09-11       Impact factor: 16.971

3.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

4.  Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR.

Authors:  R E Lanford; C Sureau; J R Jacob; R White; T R Fuerst
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

5.  Peripheral mononuclear cells of haemophiliacs with chronic liver disease are infected with replicating hepatitis C virus.

Authors:  C Henin; M Makris; J Brown; I R Peake; E F Preston
Journal:  Br J Haematol       Date:  1994-05       Impact factor: 6.998

6.  Specific detection of positive and negative stranded hepatitis C viral RNA using chemical RNA modification.

Authors:  T Gunji; N Kato; M Hijikata; K Hayashi; S Saitoh; K Shimotohno
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

7.  Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells.

Authors:  M Willems; K Peerlinck; H Moshage; I Deleu; C Van den Eynde; J Vermylen; S H Yap
Journal:  J Med Virol       Date:  1994-03       Impact factor: 2.327

8.  Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA.

Authors:  L Muratori; F Giostra; M Cataleta; R Francesconi; G Ballardini; F Cassani; M Lenzi; F B Bianchi
Journal:  Liver       Date:  1994-06

9.  The physical state of the negative strand of hepatitis C virus RNA in serum of patients with chronic hepatitis C.

Authors:  M Shindo; A M Di Bisceglie; T Akatsuka; T L Fong; L Scaglione; M Donets; J H Hoofnagle; S M Feinstone
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

10.  Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

Authors:  A J Weiner; G Kuo; D W Bradley; F Bonino; G Saracco; C Lee; J Rosenblatt; Q L Choo; M Houghton
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

View more
  52 in total

1.  HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication?

Authors:  V Meier; S Mihm; P Braun Wietzke; G Ramadori
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees.

Authors:  Y K Shimizu; H Igarashi; T Kanematu; K Fujiwara; D C Wong; R H Purcell; H Yoshikura
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients.

Authors:  Yuhki Yamaguchi; Keisuke Hino; Daisuke Fujiwara; Fenyu Ren; Yoshiharu Katoh; Yasuhiro Satoh; Kiwamu Okita
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

4.  Effect of in vitro interferon-beta administration on hepatitis C virus in peripheral blood mononuclear cells as a predictive marker of clinical response to interferon treatment for chronic hepatitis C.

Authors:  Kaori Mochizuki; Tatehiro Kagawa; Shinji Takashimizu; Kazuya Kawazoe; Sei-Ichiro Kojima; Naruhiko Nagata; Atsushi Nakano; Yasuhiro Nishizaki; Koichi Shiraishi; Masaru Itakura; Norihito Watanabe; Tetsuya Mine; Shohei Matsuzaki
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

5.  Hepatitis C virus infection of human T lymphocytes is mediated by CD5.

Authors:  Mohammed A Sarhan; Tram N Q Pham; Annie Y Chen; Tomasz I Michalak
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

6.  Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus.

Authors:  Takasuke Fukuhara; Hiroto Kambara; Mai Shiokawa; Chikako Ono; Hiroshi Katoh; Eiji Morita; Daisuke Okuzaki; Yoshihiko Maehara; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

7.  Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses.

Authors:  Pablo Sarobe; Juan José Lasarte; Aintzane Zabaleta; Laura Arribillaga; Ainhoa Arina; Ignacio Melero; Francisco Borrás-Cuesta; Jesús Prieto
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA.

Authors:  J T Stapleton; D Klinzman; W N Schmidt; M A Pfaller; P Wu; D R LaBrecque; J q Han; M J Phillips; R Woolson; B Alden
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 9.  The hepatitis C virus persistence: how to evade the immune system?

Authors:  Nicole Pavio; Michael M C Lai
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

10.  HCV replication in PBMC and its influence on interferon therapy.

Authors:  Guo-Zhong Gong; Li-Ying Lai; Yong-Fang Jiang; Yan He; Xian-Shi Su
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.